Welsh School of Pharmacy

Broadley, K.J., Blair A.E., Kidd, E.J., Bugert J.J., Ford, W.R. (2010). Bradykinin-induced lung inflammation and bronchoconstriction: role in PIV-3-induced inflammation and airways hyperreactivity J. Pharmacol. Exp. Ther. 335, 681-692.

Fehler, M., Broadley, K.J., Ford, W.R., Kidd, E.J. (2010). Identification of trace amine-associated receptors (TAAR) in the aorta and their role in vasoconstriction by β-phenylethylamine. Naunyn-Schmiedeberg’s Arch. Pharmacol. 382, 385-398.

Turner, D.L., Ferrari, N., Ford, W.R., Kidd, E.J., Paquet, L., Renzi, P., Broadley, K.J. (2010). TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol. Eur. J Pharmacol. 641, 213-219.

Fernandez-Rodriguez,S., Broadley, K. J., Ford, W. R., Kidd, E. J. (2010). Increased muscarinic receptor activity of airway smooth muscle isolated from a model of allergic asthma. Pulm. Pharmacol. Ther. 23, 300-307.

Broadley, K. J., Anwar, M.A., Herbert, A.A., Fehler, M., Jones, E.M., Davies, W.E., Kidd, E.J. & Ford W.R. (2009) Effects of dietary amines on the gut and its vasculature. Br. J. Nutrition 101, 1645-1652.

Penson, P.E., Ford, W.R., Kidd, E.J. & Broadley, K.J. (2008)Activation of β-adrenoceptors mimics preconditioning of isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn-Schmiedeberg’s Arch Pharmacol 378, 587-597.

Fernandez-Rodriguez, S., Ford, W.R., Broadley, K.J. & Kidd, E.J.
Establishing the phenotype in novel acute and chronic murine models of
allergic asthma. Int Immunopharmacol 8, 756-63 (2008).

Penson, P.E., Ford, W.R. & Broadley, K.J. Vasopressors for cardiopulmonary
resuscitation. Does pharmacological evidence support clinical practice?
Pharmacol Ther 115, 37-55 (2007).

Ford, W.R. (2006). Interpreting antioxidant responses to angiotensin AT1
receptor antagonist: pharmacology or chemistry? J Hypertension 24:1013-1016

Underdown N.J., Hiley C.R., Ford W.R. (2005). Anandamide reduces infarct
size in rat isolated hearts subjected to ischaemia-reperfusion by a novel
cannabinoid mechanism. Br J Pharmacol 146: 809-816

Fletcher A.J.W., Forhead A.J., Fowden A.L., Ford W.R., Nathanielsz P.W.,
Giussani D.A. (2005). Effects of gestational age and cortisol treatment on
ovine fetal heart function in a novel biventricular Langendorff preparation.
J Physiol 262: 493-505.

Hiley C.R. and Ford W.R. (2004). Cannabinoid pharmacology in the
cardiovascular system: potential protective mechanisms through lipid
signaling. Biol. Rev. 79: 187-205.

Kumar, D., V. Menon, Ford, W.R., Clanachan, A.S. and Jugdutt, B.J. (2004).
"Effect of angiotensin II type 2 receptor blockade on mitogen activated
protein kinases during myocardial ischemia-reperfusion." Mol Cell Biochem
258(1-2): 211-8.

Underdown N.J., Ford W.R. (2004). Anandamide reduces infarct size by a mechanism independent of CB1 or CB2 receptor activation. pA2 online, 091P. (British Pharmacological Society meeting, Bath, 5th –8th July).

Hiley C.R. and Ford W.R. (2004). Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signaling. Biol. Rev. 79: 187–205.

Underdown N.J., Ford W.R. (2003). Mechanism of anandamide-induced positive chronotropy. pA2 online, 161P. (British Pharmacological Society meeting, London, 16-18th December).

Ford W.R. and Hiley C.R. (2003). Anandamide limits infarction after ischaemia-reperfusion. Invited speaker: International Association for Cannabis as Medicine. 2nd Conference, Cologne, 12-13th September.

Hiley C.R. and Ford W.R. (2003). Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? Br J Pharmacol 138: 1183-4

Kumar, D., Menon, V.,Ford W.R. ,Clanachan A.S., Jugdutt, B.I. (2003). Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion. J Cardiovasc Pharmacol Ther 8(4): 285-96

Ford W.R. , Honan SA, White R, Hiley C.R (2002). Evidence of a novel site mediating anandamide-induced negative inotropy and coronary vasodilatator responses. Br J Pharmacol 135: 1191-1198

Xu Y, Kumar D, Dyck JR, Ford W.R. , Clanachan AS, Lopaschuk GD, Jugdutt BI (2002). AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion. Am J Physiol 282(4):H1206-15

White R, Ho W-SV, Botrill FE, Ford W.R. , Hiley CR. (2001). Mechanisms of anandamide-induced vasorelaxation in isolated coronary arteries. Br J Pharmacol. 134: 921-929

Ford W.R. , Clanachan AS, Hiley CR, Jugdutt BI (2001). Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction. Br J Pharmacol 134: 38-45